These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of oncogenic nitrosourea on intraocular tumor induction by adenovirus in rats. Kobayashi S; Ogawa K Acta Med Okayama; 1983 Feb; 37(1):45-9. PubMed ID: 6846051 [TBL] [Abstract][Full Text] [Related]
23. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis. Sheil JM; Gallimore PH; Zimmer SG; Sopori ML J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497 [TBL] [Abstract][Full Text] [Related]
24. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes. Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969 [TBL] [Abstract][Full Text] [Related]
25. Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction. Boonman ZF; van Mierlo GJ; Fransen MF; Franken KL; Offringa R; Melief CJ; Jager MJ; Toes RE J Immunol; 2004 Feb; 172(3):1567-74. PubMed ID: 14734736 [TBL] [Abstract][Full Text] [Related]
26. [Various indicators of cellular and humoral immunity in children with retinoblastoma]. Khvatova AV; Skriabina OA; Katargina LA; Murav'eva TV Vestn Oftalmol; 1988; 104(1):43-5. PubMed ID: 3369043 [No Abstract] [Full Text] [Related]
27. Electron microscopy and HLA expression of a new cell line of retinoblastoma. Fournier GA; Sang DN; Albert DM; Craft JL Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):690-9. PubMed ID: 3549617 [TBL] [Abstract][Full Text] [Related]
28. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays. Steele G; Sjögren HO; Lannerstad O; Stadenberg I Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212 [TBL] [Abstract][Full Text] [Related]
29. Cutaneous delayed hypersensitivity responses of patients with retinoblastoma to standard recall antigens and crude membrane extracts of retino-blastoma tissue culture cells. Char DH; Herberman RB Am J Ophthalmol; 1974 Jul; 78(1):40-4. PubMed ID: 4600659 [No Abstract] [Full Text] [Related]
30. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. Niederkorn JY; Streilein JW J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396 [TBL] [Abstract][Full Text] [Related]
31. Surface and cytoplasmic antigens in retinoblastoma. Felberg NT; Donoso LA Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1242-5. PubMed ID: 7419374 [TBL] [Abstract][Full Text] [Related]
32. Specific cytotoxicity in vitro by T-cell-enriched lymphocyte subpopulations from rats bearing chemically induced but not spontaneous tumors. Zöller M; Matzku S J Natl Cancer Inst; 1980 Oct; 65(4):769-79. PubMed ID: 6968370 [TBL] [Abstract][Full Text] [Related]
33. CTL recognition of adenovirus-transformed cells infected with influenza virus: lysis by anti-influenza CTL parallels adenovirus-12-induced suppression of class I MHC molecules. Yewdell JW; Bennink JR; Eager KB; Ricciardi RP Virology; 1988 Jan; 162(1):236-8. PubMed ID: 2827381 [TBL] [Abstract][Full Text] [Related]
34. Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma. Touitou V; Daussy C; Bodaghi B; Camelo S; de Kozak Y; Lehoang P; Naud MC; Varin A; Thillaye-Goldenberg B; Merle-Béral H; Fridman WH; Sautès-Fridman C; Fisson S Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3223-9. PubMed ID: 17591892 [TBL] [Abstract][Full Text] [Related]
35. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma. Knisely TL; Niederkorn JY Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):247-57. PubMed ID: 2154414 [TBL] [Abstract][Full Text] [Related]
36. Toxicity of a monoclonal F(ab')2:ricin A conjugate for retinoblastoma in vitro. Merriam JC; Lyon HS; Char DH Cancer Res; 1984 Aug; 44(8):3178-83. PubMed ID: 6744258 [TBL] [Abstract][Full Text] [Related]
37. Cell-mediated immunity to retinal antigens in patients with pigmentary retinal degenerations. Char DH; Bergsma DR; Rabson AS; Albert DM; Herberman RB Invest Ophthalmol; 1974 Mar; 13(3):198-203. PubMed ID: 4813702 [No Abstract] [Full Text] [Related]
38. Anti-leukocyte function-1 antibody treatment prevents the rejection of intraocular regressor tumors and their metastases. Li XY; Mayhew E; Niederkorn JY Curr Eye Res; 1995 Aug; 14(8):719-26. PubMed ID: 8529408 [TBL] [Abstract][Full Text] [Related]
39. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. McEvoy RC; Andersson J; Sandler S; Hellerström C J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584 [TBL] [Abstract][Full Text] [Related]
40. Transplantation of Y79 cells into rat eyes: an in vivo model of human retinoblastomas. del Cerro M; Seigel GM; Lazar E; Grover D; del Cerro C; Brooks DH; DiLoreto D; Chader G Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3336-46. PubMed ID: 8225869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]